@article{UBHD-68441083, author={Gong, Wenjie and Hoffmann, Jean-Marc and Stock, Sophia and Wang, Lei and Liu, Yibin and Schubert, Maria-Luisa and Neuber, Brigitte and H{\"u}ckelhoven-Krauss, Angela and Gern, Ulrike and Schmitt, Anita and M{\"u}ller-Tidow, Carsten and Shiku, Hiroshi and Schmitt, Michael and Sellner, Leopold}, title={Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells}, year={2019}, pages={1195-1209}, language={eng}, issn={1432-0851}, volume={68}, number={7}, note={Published online: 8 June 2019 ; Gesehen am 16.10.2019}, journal={Cancer immunology immunotherapy}, doi={10.1007/s00262-019-02354-4}, } @article{UBHD-68929774, author={Gong, Wenjie and Wang, Lei and Schubert, Maria-Luisa and Kleist, Christian and Neuber, Brigitte and Wang, Sanmei and Yang, Mingya and H{\"u}ckelhoven-Krauss, Angela and Wu, Depei and Schmitt, Anita and M{\"u}ller-Tidow, Carsten and Shiku, Hiroshi and Schmitt, Michael and Sellner, Leopold}, title={HDAC inhibition for optimized cellular immunotherapy of NY-ESO-1-positive soft tissue sarcoma}, year={2022}, pages={1-14}, language={eng}, issn={2227-9059}, volume={10}, note={Gesehen am 12.06.2022}, journal={Biomedicines}, doi={10.3390/biomedicines10020373}, } @book{UBHD-68432340, author={Gong, Wenjie}, organization={Universit{\"a}t Heidelberg}, title={Optimization of adoptive immunotherapy with genetically engineered T cells}, address={Heidelberg}, year={2019}, pages={x, 99 Bl{\"a}tter}, language={eng}, school={Dissertation, Ruprecht-Karls-Universit{\"a}t Heidelberg, 2019}, library={UB [Signatur: 2019 U 729]}, } @article{UBHD-68413069, author={Stock, Sophia and {\"U}belhart, Rudolf and Schubert, Maria-Luisa and Fan, Fuli and He, Bailin and Hoffmann, Jean-Marc and Wang, Lei and Wang, Sanmei and Gong, Wenjie and Neuber, Brigitte and H{\"u}ckelhoven-Krauss, Angela and Gern, Ulrike and Christ, Christiane and Hexel, Monika and Schmitt, Anita and Schmidt, Patrick and Krauß, J{\"u}rgen and J{\"a}ger, Dirk and M{\"u}ller-Tidow, Carsten and Dreger, Peter and Schmitt, Michael and Sellner, Leopold}, title={Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients}, year={2019}, pages={1312-1324}, language={eng}, issn={1097-0215}, volume={145}, number={5}, note={Gesehen am 26.07.2019}, journal={International journal of cancer}, doi={10.1002/ijc.32201}, } @article{UBHD-68565691, author={Stock, Sophia and Hoffmann, Jean-Marc and Schubert, Maria-Luisa and Wang, Lei and Wang, Sanmei and Gong, Wenjie and Neuber, Brigitte and Gern, Ulrike and Schmitt, Anita and M{\"u}ller-Tidow, Carsten and Dreger, Peter and Schmitt, Michael and Sellner, Leopold}, title={Influence of retronectin-mediated T-cell activation on expansion and phenotype of CD19-specific chimeric antigen receptor T cells}, year={2018}, pages={1167-1182}, language={eng}, issn={1557-7422}, volume={29}, number={10}, note={Gesehen am 17.04.2020}, journal={Human gene therapy}, doi={10.1089/hum.2017.237}, } @article{UBHD-68432373, author={Wang, Lei and Gong, Wenjie and Wang, Sanmei and Neuber, Brigitte and Sellner, Leopold and Schubert, Maria-Luisa and H{\"u}ckelhoven-Krauss, Angela and Kunz, Alexander and Gern, Ulrike and Michels, Birgit and Hinkelbein, Mandy and Mechler, Stefanie and Richter, Petra and M{\"u}ller-Tidow, Carsten and Schmitt, Michael and Schmitt, Anita}, title={Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells}, year={2019}, pages={566-578}, language={eng}, issn={1477-2566}, volume={21}, number={5}, note={Gesehen am 23.09.2019}, journal={Cytotherapy}, doi={10.1016/j.jcyt.2019.02.013}, } @article{UBHD-68877889, author={Wang, Sanmei and Sellner, Leopold and Wang, Lei and Sauer, Tim and Neuber, Brigitte and Gong, Wenjie and Stock, Sophia and Ni, Ming and Yao, Hao and Kleist, Christian and Schmitt, Anita and M{\"u}ller-Tidow, Carsten and Schmitt, Michael and Schubert, Maria-Luisa}, title={Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies}, year={2021}, pages={1-12}, language={eng}, issn={1021-335X}, volume={46}, number={Artikel-ID 170}, journal={Oncology reports}, doi={10.3892/or.2021.8121}, }